Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

Synthesis of subtype selective ligands for ?5 containing GABAA/BZ receptors to treat memory deficits

T Clayton , Margot Ernst , Lars Richter , S Sanker , Timothy M. DeLorey , Werner Sieghart , R Furtmüller , Gerhard Ecker , J M Cook
238th American Chemical Society National Meeting & Exposition
Conference, Poster presentation
..2009 - ..2009

Synthesis, spasmolytic activity and structure-activity relationship studies of a series of thiobenzanilides

Christian Studenik , Thomas Erker , Gerda Brunhofer-Bolzer , Gerhard Ecker
Nicht angegeben
Other, Poster presentation
..2009 - ..2009

Using multiple approaches in docking pose evaluation – application to the GABA-A receptor

Lars Richter , Margot Ernst , Werner Sieghart , Gerhard Ecker
21. Wissenschaftliche Tagung der Österreichischen Pharmazeutischen Gesellschaft
Conference, Poster presentation
..2009 - ..2009

Safety Sciences in silico - Analyse unerwünschter Wirkungen durch molekulare Modellierung

Gerhard Ecker
5. Wissenschaftliches Symposium der Österreichischen Gesellschaft für Toxikologie
Conference, Talk or oral contribution
19.11.2008 - 19.11.2008

Optimising ligands for promiscuous targets - a case study for P-glycoprotein inhibitors

Gerhard Ecker
BIT's 6th Annual Congress of International Drug Discovery Science and Technology
Conference, Talk or oral contribution
20.10.2008 - 20.10.2008